Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2
about
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Phase I Study of Cellular Immu ...... umoral Infusions of GRm13Z40-2
@en
Phase I Study of Cellular Immu ...... umoral Infusions of GRm13Z40-2
@nl
type
label
Phase I Study of Cellular Immu ...... umoral Infusions of GRm13Z40-2
@en
Phase I Study of Cellular Immu ...... umoral Infusions of GRm13Z40-2
@nl
prefLabel
Phase I Study of Cellular Immu ...... umoral Infusions of GRm13Z40-2
@en
Phase I Study of Cellular Immu ...... umoral Infusions of GRm13Z40-2
@nl
P1050
P3098
NCT01082926